Yubo International Biotech Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.42851 million compared to USD 0.01458 million a year ago. Net income was USD 0.006293 million compared to net loss of USD 0.238096 million a year ago.
For the nine months, sales was USD 0.58239 million compared to USD 0.037763 million a year ago. Net loss was USD 0.677701 million compared to USD 1.31 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.